The protective effect of rivaroxaban with or without aspirin on inflammation, oxidative stress, and platelet reactivity in isoproterenol-induced cardiac injury in rats

Abbate A, Trankle CR, Buckley LF, Lipinski MJ, Appleton D, Kadariya D, Canada JM, Carbone S, Roberts CS, Abouzaki N, Melchior R, Christopher S, Turlington J, Mueller G, Garnett J, Thomas C, Markley R, Wohlford GF, Puckett L, Van Tassell BW (2020) Interleukin-1 blockade inhibits the acute inflammatory response in patients with ST-segment-elevation myocardial infarction. J Am Heart Assoc 9(5):1–9. https://doi.org/10.1161/JAHA.119.014941

Article  Google Scholar 

Allawadhi P, Khurana A, Sayed N, Kumari P, Godugu C (2018) Isoproterenol-induced cardiac ischemia and fibrosis: Plant-based approaches for intervention. Phytother Res 32(10):1908–1932. https://doi.org/10.1002/ptr.6152

Article  PubMed  Google Scholar 

Alyavi BA, Uzokov JK, Mukhitdinova O (2021) Antiplatelet therapy in coronary artery disease. Indian J Forensic Med Toxicol 15(3):2111–2115. https://doi.org/10.37506/ijfmt.v15i3.15628

Article  CAS  Google Scholar 

Ambler J, Butler KD, Ku EC, Maguire ED, Smith JR, Wallis RB (1985) CGS 12970: a novel, long acting thromboxane synthetase inhibitor. Br J Pharmacol 86(2):497–504. https://doi.org/10.1111/j.1476-5381.1985.tb08920.x

Article  CAS  PubMed  PubMed Central  Google Scholar 

Antoniak S, Rojas M, Spring D, Bullard TA, Verrier ED, Blaxall BC, Mackman N, Pawlinski R (2010) Protease-activated receptor 2 deficiency reduces cardiac ischemia/reperfusion injury. Arterioscler Thromb Vasc Biol 30(11):2136–2142. https://doi.org/10.1161/ATVBAHA.110.213280

Article  CAS  PubMed  PubMed Central  Google Scholar 

Badimon L, Vilahur G (2014) Thrombosis formation on atherosclerotic lesions and plaque rupture. J Intern Med 276(6):618–632. https://doi.org/10.1111/joim.12296

Article  CAS  PubMed  Google Scholar 

Badimon L, Padró T, Vilahur G (2012) Atherosclerosis, platelets and thrombosis in acute ischaemic heart disease. Eur Heart J Acute Cardiovasc Care 1(1):60–74. https://doi.org/10.1177/2048872612441582

Article  PubMed  PubMed Central  Google Scholar 

Bakogiannis C, Sachse M, Stamatelopoulos K, Stellos K (2019) Platelet-derived chemokines in inflammation and atherosclerosis. Cytokine 122:1–10. https://doi.org/10.1016/j.cyto.2017.09.013

Article  CAS  Google Scholar 

Barbarawi M, Kheiri B, Zayed Y, Gakhal I, Al-Abdouh A, Barbarawi O, Rashdan L, Rizk F, Bachuwa G, Alkotob ML (2019) Aspirin efficacy in primary prevention: a meta-analysis of randomized controlled trials. High Blood Press Cardiovasc Prev 26(4):283–291. https://doi.org/10.1007/s40292-019-00325-5

Article  CAS  PubMed  Google Scholar 

Barisione G, Baroffio M, Crimi E, Brusasco V (2010) Beta-Adrenergic Agonists. Pharmaceuticals 3(4):1016–1044. https://doi.org/10.3390/ph3041016

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barrios V, Almendro-Delia M, Facila L, Garcia-Moll X, Mazon P, Camafort M, María Cepeda J, Mediavilla Garcia JD, Pose Reino A, Suarez Fernandez C (2018) Rivaroxaban: searching the integral vascular protection. Expert Rev Clin Pharmacol 11(7):719–728. https://doi.org/10.1080/17512433.2018.1495559

Article  CAS  PubMed  Google Scholar 

Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, Chiuve SE, Cushman M, Delling FN, Deo R, De Ferranti SD, Ferguson JF, Fornage M, Gillespie C, Isasi CR, Jiménez MC, Jordan LC, Judd SE, Lackland D, Muntner P (2018) Heart disease and stroke statistics - 2018 update: a report from the American Heart Association. Circulation 137(12):67–492. https://doi.org/10.1161/CIR.0000000000000558

Article  Google Scholar 

Bentzon JF, Otsuka F, Virmani R, Falk E (2014) Mechanisms of plaque formation and rupture. Circ Res 114(12):1852–1866. https://doi.org/10.1161/CIRCRESAHA.114.302721

Article  CAS  PubMed  Google Scholar 

Bodor GS (2016) Biochemical markers of myocardial damage. J Int Fed Clin Chem Lab Med 27(2):95–111

CAS  Google Scholar 

Borissoff JI, Spronk HM, Heeneman S, Ten Cate H (2009) Is thrombin a key player in the “coagulation-atherogenesis” maze? Cardiovasc Res 82(3):392–403. https://doi.org/10.1093/cvr/cvp066

Article  CAS  PubMed  Google Scholar 

Borissoff JI, Heeneman S, Kilinç E, Kaššák P, Van Oerle R, Winckers K, Govers-Riemslag JW, Hamulyák K, Hackeng TM, Daemen MJ, Ten Cate H, Spronk HM (2010) Early atherosclerosis exhibits an enhanced procoagulant state. Circulation 122(8):821–830. https://doi.org/10.1161/CIRCULATIONAHA.109.907121

Article  CAS  PubMed  Google Scholar 

Busch G, Seitz I, Steppich B, Hess S, Eckl R, Schömig A, Ott I (2005) Coagulation factor Xa stimulates interleukin-8 release in endothelial cells and mononuclear leukocytes implications in acute myocardial infarction. Atheroscler Thromb Vasc Biol 25(2):461–466. https://doi.org/10.1161/01.ATV.0000151279.35780.2d

Article  CAS  Google Scholar 

Cammisotto V, Carnevale R, Nocella C, Stefanini L, Bartimoccia S, Coluccia A, Silvestri R, Pignatelli P, Pastori D, Violi F (2019) Nox2-mediated platelet activation by glycoprotein (GP) VI: effect of rivaroxaban alone and in combination with aspirin. Biochem Pharmacol 163:111–118. https://doi.org/10.1016/j.bcp.2019.02.016

Article  CAS  PubMed  Google Scholar 

Capodanno D, Mehran R, Valgimigli M, Baber U, Windecker S, Vranckx P, Dangas G, Rollini F, Kimura T, Collet JP, Gibson CM, Steg PG, Lopes RD, Gwon HC, Storey RF, Franchi F, Bhatt DL, Serruys PW, Angiolillo DJ (2018) Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention. Nat Rev Cardiol 15(8):480–496

Article  CAS  PubMed  Google Scholar 

Carretero A, Gomez-Cabrera MC, Rios-Navarro C, Salvador-Pascual A, Bodi V, Viña J (2020) Early reductive stress and late onset overexpression of antioxidant enzymes in experimental myocardial infarction. Free Radical Res 54(2–3):173–184. https://doi.org/10.1080/10715762.2020.1735632

Article  CAS  Google Scholar 

Coppens M, Weitz JI, Eikelboom JW (2019) Synergy of dual pathway inhibition in chronic cardiovascular disease: lessons from the COMPASS trial. Circ Res 124(3):416–425. https://doi.org/10.1161/CIRCRESAHA.118.313141

Article  CAS  PubMed  Google Scholar 

Corbi G, Conti V, Russomanno G, Longobardi G, Furgi G, Filippelli A, Ferrara N (2013) Adrenergic signaling and oxidative stress: a role for sirtuins? Front Physiol 4:1–14. https://doi.org/10.3389/fphys.2013.00324

Article  Google Scholar 

Daci A, Da Dalt L, Alaj R, Shurdhiqi S, Neziri B, Ferizi R, Norata GD, Krasniqi S (2020) Rivaroxaban improves vascular response in LPS-induced acute inflammation in experimental models. PLoS One 15(12):1–16. https://doi.org/10.1371/journal.pone.0240669

Article  CAS  Google Scholar 

Dayana K, Manasa MR (2019) Evaluation of the effect of ceftriaxone on lipid peroxidation and antioxidant levels in mice. Biomed Pharmacol J 12(1):245–250. https://doi.org/10.13005/bpj/1634

Article  CAS  Google Scholar 

De Candia E (2012) Mechanisms of platelet activation by thrombin: a short history. Thromb Res 129(3):250–256. https://doi.org/10.1016/j.thromres.2011.11.001

Article  CAS  PubMed  Google Scholar 

Dejana E, Callioni A, Quintana A (1979) Bleeding time in laboratory animals. II - a comparison of different assay conditions in rats. Thromb Res 15(1–2):191–197

Article  CAS  PubMed  Google Scholar 

Dhalla NS, Adameova A, Kaur M (2010) Role of catecholamine oxidation in sudden cardiac death. Fundam Clin Pharmacol 24(5):539–546. https://doi.org/10.1111/j.1472-8206.2010.00836.x

Article  CAS  PubMed  Google Scholar 

Eikelboom JW, Connolly SJ, Bosch J, Dagenais GR, Hart RG, Shestakovska O, Diaz R, Alings M, Lonn EM, Anand SS, Widimsky P, Hori M, Avezum A, Piegas LS, Branch KRH, Probstfield J, Bhatt DL, Zhu J, Liang Y, Yusuf S (2017) Rivaroxaban with or without aspirin in stable cardiovascular disease. N Engl J Med 377(14):1319–1330. https://doi.org/10.1056/nejmoa1709118

Article  CAS  PubMed  Google Scholar 

Eller T, Busse J, Dittrich M, Flieder T, Alban S, Knabbe C, Birschmann I (2014) Dabigatran, rivaroxaban, apixaban, argatroban and fondaparinux and their effects on coagulation POC and platelet function tests. Clin Chem Lab Med 52(6):835–844. https://doi.org/10.1515/cclm-2013-0936

Article  CAS  PubMed  Google Scholar 

Forte E, Panahi M, Baxan N, Ng FS, Boyle JJ, Branca J, Bedard O, Muneer Hasham MG, Benson L, Harding SE, Rosenthal N, Sattler S (2021) Type 2 MI induced by a single high dose of isoproterenol in C57BL/6 J mice triggers a persistent adaptive immune response against the heart. J Cell Mol Med 25(1):229–243. https://doi.org/10.1111/jcmm.15937

Article  CAS  PubMed  Google Scholar 

Fuentes E, Moore-Carrasco R, de Andrade Paes AM, Trostchansky A (2019) Role of platelet activation and oxidative stress in the evolution of myocardial infarction. J Cardiovasc Pharmacol Ther 24(6):509–520. https://doi.org/10.1177/1074248419861437

Article  CAS  PubMed  Google Scholar 

Garlie JB, Hamid T, Gu Y, Ismahil MA, Chandrasekar B, Prabhu SD (2011) Tumor necrosis factor receptor 2 signaling limits β-adrenergic receptor-mediated cardiac hypertrophy in vivo. Basic Res Cardiol 106(6):1193–1205. https://doi.org/10.1007/s00395-011-0196-6

Article  CAS  PubMed  Google Scholar 

Gosselin R, Grant RP, Adcock DM (2016) Comparison of the effect of the anti-Xa direct oral anticoagulants apixaban, edoxaban, and rivaroxaban on coagulation assays. Int J Lab Hematol 38(5):505–513. https://doi.org/10.1111/ijlh.12528

Article  CAS  PubMed  Google Scholar 

Graff J, Von Hentig N, Misselwitz F, Kubitza D, Becka M, Breddin HK, Harder S (2007) Effects of the oral, direct factor Xa inhibitor rivaroxaban on platelet-induced thrombin generation and prothrombinase activity. J Clin Pharmacol 47(11):1398–1407. https://doi.org/10.1177/0091270007302952

Article  CAS  PubMed  Google Scholar 

Grant MK, Abdelgawad IY, Lewis CA, Seelig D, Zordoky BN (2020) Lack of sexual dimorphism in a mouse model of isoproterenol-induced cardiac dysfunction. PLoS One 15(7):1–19. https://doi.org/10.1371/journal.pone.0232507

Article  CAS 

留言 (0)

沒有登入
gif